DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Emivirine
Emivirine
HIV-Infected Patients
( 12 ) United States Patent
Canadian HIV/AIDS Pharmacists Network (CHAP) Newsletter – April 2000
Meeting Report: 26Th International Conference on Antiviral Research Q
Modifications to the Harmonized Tariff Schedule of the United States To
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
This Project Has Been Supported with Unrestriced Grants from Abbvie Gilead Sciences HEXAL Janssen-Cilag MSD Viiv Healthcare By
Emtricitabine/Tenofovir Alafenamide Fixed-Dose Combination (F/Taf Fdc)
I Regulations
Background Paper 6.7 Human Immunodeficiency Virus (HIV)/ Acquired Immune Deficiency Syndromes (AIDS)
Short Communication Compilation and Prevalence of Mutations Associated with Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
Stembook 2018.Pdf
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
Hoffmann Rockstroh |
Repurposing of FDA Approved Drugs
Pharmaceutical Appendix to the Tariff Schedule 2
Women's Interagency Hiv Study Drug List 1 – By
MTN-034 Study Protocol
Top View
Hiv 2012/2013
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
WO 2013/116720 Al 8 August 2013 (08.08.2013) P O P C T
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
HICDEP: HIV Cohorts Data Exchange Protocol
WO 2U11/1U6445 Al
Approved Antiviral Drugs Over the Past 50 Years
(12) Patent Application Publication (10) Pub. No.: US 2015/0322155A1 Zhao (43) Pub
Anti-HIV Drugs: 25 Compounds Approved Within 25 Years After the Discovery of HIVଝ
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 9,708,342 B2 Carra Et Al
Investigational Drugs in HIV Therapy: Review of Select New Antiretrovirals
Program and Abstracts of the Twenty-Fifth International
Eng. Thesaurus V4 Forpdf
Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed-Dose Combination (B/F/Taf Fdc)
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: a Review of Recent Advances and Structure-Activity Relationship Studies
Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: a Combinatorial Approach
COVID User's Guide (Updated: 14/12/2020)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Non-Nucleoside Reverse Transcriptase Inhibitors In
Program and Abstracts International Conference Antiviral Research
L:\0900\0900PHARMAPPX .Wpd
Us 2019 / 0127401 A1
WO 2018/193470 Al 25 October 2018 (25.10.2018) W !P O PCT
Learningpharmacology 2018.Pdf
D:\Stuff Word\DL1-0402.Wpd
WO 2016/059622 A2 21 April 2016 (21.04.2016) P O P C T
US20110312880A1.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2014/0288017 A1 Jorgensen Et Al